Cochrane · systematic review · CD013093

Betahistine for tinnitus

Wegner, I, Hall, DA, Smit, AL, et al. · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library

ENTAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
17
current version
GRADE rated
12
No studies
5
Included studies
NR
No studies 5 · 29.4%Ungraded 0 · 0%Very low 5 · 29.4%Low 2 · 11.8%Moderate 5 · 29.4%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Betahistine compared with placebo for tinnitus

Population: patients with subjective idiopathic tinnitus
11 questions
OutcomeEffectEvidenceStatus / GRADE
Tinnitus loudness measured by a visual analogue scale (range 0 to 10/more than 10)
Betahistine vs placebo
no estimate extracted2 studies · 81 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Change in tinnitus loudness measured by a visual analogue scale (range 0 to more than 10)
Betahistine vs placebo
no estimate extracted1 study · 11 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Tinnitus loudness measured by a visual analogue scale (range 0 to 10)
Betahistine vs placebo
no estimate extracted1 study · 70 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Significant adverse effects (yes or no)
Betahistine vs placebo
no estimate extracted1 study · 11 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Significant adverse effects (yes or no)
Betahistine vs placebo
no estimate extracted1 study · 41 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Change in Tinnitus Severity Index (range 0 to 56)
Betahistine vs placebo
no estimate extracted1 study · 50 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Tinnitus severity score (range 0 to 4)
Betahistine vs placebo
no estimate extracted1 study · 36 participantsLow
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Depressive symptoms
Betahistine vs placebo
no estimate extractedNRNo studies
Symptoms of generalised anxiety
Betahistine vs placebo
no estimate extractedNRNo studies
Other adverse effects (yes or no)
Betahistine vs placebo
no estimate extracted1 study · 11 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Other adverse effects (yes or no)
Betahistine vs placebo
no estimate extracted1 study · 41 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, indirectness

Betahistine versus placebo (with concurrent medication)

Population: patients with subjective idiopathic tinnitus
6 questions
OutcomeEffectEvidenceStatus / GRADE
Change in tinnitus loudness match (range 0 to 5)
Betahistine vs placebo (with concurrent medication)
no estimate extracted1 study · 60 participantsModerate
Downgraded: risk of bias
Significant adverse effects (yes or no)
Betahistine vs placebo (with concurrent medication)
no estimate extracted1 study · 59 participantsLow
Downgraded: risk of bias, imprecision
Tinnitus symptom severity
Betahistine vs placebo (with concurrent medication)
no estimate extractedNRNo studies
Depressive symptoms
Betahistine vs placebo (with concurrent medication)
no estimate extractedNRNo studies
Symptoms of generalised anxiety
Betahistine vs placebo (with concurrent medication)
no estimate extractedNRNo studies
Other adverse effects (yes or no)
Betahistine vs placebo (with concurrent medication)
no estimate extracted1 study · 59 participantsModerate
Downgraded: risk of bias